Assessment for Diabetic Neuropathy: Treatment and Neurobiological Perspective

Title:Assessment for Diabetic Neuropathy: Treatment and Neurobiological Perspective

Volume: 20

Author(s): Bhanupriya Bhrigu, Shikha Sharma*, Nitin Kumar and Bimal Krishna Banik

Affiliation:

• Department of Pharmaceutical Science, Lords University, Alwar, 301028, Rajasthan, India

Abstract: Diabetic neuropathy, also known as diabetic peripheral sensorimotor neuropathy (DPN), is a consequential complexity of diabetes, alongside diabetic nephropathy, diabetic cardiomyopathy, and diabetic retinopathy. It is characterized by signs and symptoms of peripheral nerve damage in diabetes patients after ruling out other causes. Approximately 20% of people with diabetes are affected by this painful and severe condition. The development of diabetic neuropathy is influenced by factors such as impaired blood flow to the peripheral nerves and metabolic issues, including increased polyol pathway activation, myo-inositol loss, and nonenzymatic glycation. The present review article provides a brief overview of the pathological changes in diabetic neuropathy and the mechanisms and types of DPN. Various diagnostic tests and biomarkers are available to assess nerve damage and its severity. Pharmacotherapy for neuropathic pain in diabetic neuropathy is complex. This review will explore current treatment options and potential future developments to improve the quality of life for patients suffering from diabetic neuropathy.

Cite this article as:

Bhrigu Bhanupriya, Sharma Shikha*, Kumar Nitin and Banik Bimal Krishna, Assessment for Diabetic Neuropathy: Treatment and Neurobiological Perspective, Current Diabetes Reviews 2024; 20 () : e240524230300 . https://dx.doi.org/10.2174/0115733998290606240521113832